Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India

Akash Khobragade; Suresh Bhate; Vijendra Ramaiah; Shrikant Deshpande; Krishna Giri; Himanshu Phophle; Pravin Supe; Inderjeet Godara; Ramesh Revanna; Rajnish Nagarkar; Jayesh Sanmukhani; Ayan Dey; T M Chozhavel Rajanathan; Kevinkumar Kansagra; Parshottam Koradia

The Lancet (2022) - Comments
pubmed: 35367003 doi: 10.1016/s0140-6736(22)00151-9 issn: 0140-6736 issn: 1474-547x

Akash Khobragade, Suresh Bhate, Vijendra Ramaiah, Shrikant Deshpande, Krishna Giri, Himanshu Phophle, Pravin Supe, Inderjeet Godara, Ramesh Revanna, Rajnish Nagarkar, Jayesh Sanmukhani, Ayan Dey, T M Chozhavel Rajanathan, Kevinkumar Kansagra, Parshottam Koradia